Loading your page…
Each register with its number of medicines and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
CBG-MEB · 1 medicine
ALIMS · 1 medicine
SFDA · 1 medicine · Historical list
Every register, a page at a time. Strengths and packs are on each medicine’s page.
11 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Panhematin | Canada | 268 MG / VIAL | Powder For Solution | Marketed | Recordati Rare Diseases Canada INC |
| NORMOSANG 25 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION | Spain | 25 mg | concentrado para solución para perfusión | Marketed | Recordati Rare Diseases |
| Panhematin | Brazil | Authorised | Recordati Rare Diseases Comércio de Medicamentos Ltda - Me | ||
| Normosang | Italy | Concentrato per soluzione per infusione | Authorised | Recordati Rare Diseases Sarl | |
| Normosang 25 mg/ml, concentraat voor oplossing voor infusie | Netherlands | Concentraat voor oplossing voor infusie | Authorised | Recordati Rare Diseases | |
| Normosang®Combination | Serbia | 25mg/mL | koncentrat za rastvor za infuziju | Authorised | Clinres Farmacija D.O.O. Beograd |
| Panhematin | United States | 350MG | For Injection | Marketed | Recordati Rare Diseases, Inc. |
| Normosang | Saudi Arabia | Authorised | Ever Pharma Jena GMBH | ||
| Dipleksil 250 mg želučanootoporne tablete | Croatia | Želučanootporna tableta | Marketed | Tecnifar Industria Tecnica Farmaceutica S.A., Torre Sul, Rua José Da Costa Pedreira 11 B, Lisabon, Portugal | |
| Dipleksil 500 mg želučanootoporne tablete | Croatia | Želučanootporna tableta | Marketed | Tecnifar Industria Tecnica Farmaceutica S.A., Torre Sul, Rua José Da Costa Pedreira 11 B, Lisabon, Portugal | |
| Normosang 25 mg/ml koncentrat za otopinu za infuziju | Croatia | koncentrat za otopinu za infuziju | Marketed | Recordati Rare Diseases, Tour Hekla, 52 avenue du Général de Gaulle, Puteaux, Francuska |
The same brand on several registers.
The companies holding its medicines, the most first.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, ALIMS, Anvisa, CBG-MEB, Health Canada and SFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
